Trustees
Since 31 January 2018, the sole trustee of the Thalidomide Trust has been ‘Thalidomide Trust Company’. The individuals who served as charity Trustees before that date now serve as the directors of the Trustee company. However, we continue to refer them as Trustees internally for continuity and because their role within the Trust remains unchanged. Our current Trustees are:
Mark Spofforth OBE, BSC, FCA, CTA, FRSA
Chair of Trustees
Trustee since December 2013
David Body
Vice – Chair of Trustees
Trustee since January 2015
Shan Abdullah
Finance Trustee
Trustee since September 2022
Mark Benstead BA, MBA
Finance Trustee
Trustee since May 2015
Ruthe Isden
Trustee since August 2021
Professor Adrian Newland CBE
Clinical Trustee
Trustee since January 2020
Professor Andrew Owens MD, FRCS(CTh)
Clinical Trustee
Trustee since January 2020
Dame Caroline Swift
Trustee since January 2023
Professor Rosemary Varley
Research trustee
Trustee since April 2020